Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-120155

SrVP/CFO/Prin Fin & Acct Ofcr bought 5,000 shares at $1.17 ($5,825)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2025-12-10 Purchase +5,000 $1.17 $5,825 27,733 D
Derivatives
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2025-12-10 Purchase · Common Warrant +5,000 5,000 D
Open-market purchases · 5,000 sh · avg $1.17 · $5,825
Loading xslF345X05/tm2533219-2_4seq1.xml…